1887

Abstract

Although the presence of micro-organisms in the blood of healthy humans is a relatively new concept, there is a growing amount of evidence that blood might have its own microbiome.

Previous research has targeted the taxonomic composition of the blood microbiome using DNA-based sequencing methods, while little information is known about the presence of microbial transcripts obtained from the blood and their relation to conditions connected with increased gut permeability.

To detect potentially alive and active micro-organisms and investigate differences in taxonomic composition between healthy people and patients with irritable bowel syndrome (IBS), we used the metatranscriptomics approach.

We collected blood samples from 23 IBS patients and 26 volunteers from the general population, and performed RNAseq on the isolated RNA. Reads corresponding to microbial genomes were identified with Kraken 2’s standard plus protozoa and fungi database, and re-estimated at genus level with Bracken 2.7. We looked for trends in the taxonomic composition, making a comparison between the IBS and control groups, accounting for other different factors.

The dominant genera in the blood microbiome were found to be , , , , , , , , and . Some of these are typical environmental bacteria and could partially represent contamination. However, analysis of sequences from the negative controls suggested that some genera which are characteristic of the gut microbiome (, , , , , , , , , , , , ) are less likely to be a result of contamination. Differential analysis of microbes between groups showed that some taxa associated with the gut microbiome (, , , , , ) are more prevalent in IBS patients compared to the general population. No significant correlations with any other factors were identified.

Our findings support the existence of the blood microbiome and suggest the gut and possibly the oral microbiome as its origin, while the skin microbiome is a possible but less certain source. The blood microbiome is likely influenced by states of increased gut permeability such as IBS.

Funding
This study was supported by the:
  • Latvijas Universitātes Fonds
    • Principle Award Recipient: MaijaRozenberga
  • ESF project “Strengthening of the Capacity of Doctoral Studies at the University of Latvia within the Framework of the New Doctoral Model” (Award 8.2.2.0/20/I/006)
    • Principle Award Recipient: MaijaRozenberga
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001719
2023-06-19
2024-05-17
Loading full text...

Full text loading...

/deliver/fulltext/jmm/72/6/jmm001719.html?itemId=/content/journal/jmm/10.1099/jmm.0.001719&mimeType=html&fmt=ahah

References

  1. Lloyd-Price J, Abu-Ali G, Huttenhower C. The healthy human microbiome. Genome Med 2016; 8:51 [View Article] [PubMed]
    [Google Scholar]
  2. Kilian M, Chapple ILC, Hannig M, Marsh PD, Meuric V et al. The oral microbiome - an update for oral healthcare professionals. Br Dent J 2016; 221:657–666 [View Article] [PubMed]
    [Google Scholar]
  3. Berg G, Rybakova D, Fischer D, Cernava T, Vergès M-C et al. Correction to: microbiome definition re-visited: old concepts and new challenges. Microbiome 2020; 8:119 [View Article] [PubMed]
    [Google Scholar]
  4. Chabé M, Lokmer A, Ségurel L. Gut Protozoa: friends or foes of the human gut microbiota?. Trends Parasitol 2017; 33:925–934 [View Article] [PubMed]
    [Google Scholar]
  5. Even G, Lokmer A, Rodrigues J, Audebert C, Viscogliosi E et al. Changes in the human gut microbiota associated with colonization by Blastocystis sp. and Entamoeba spp. in non-industrialized populations. Front Cell Infect Microbiol 2021; 11:533528 [View Article] [PubMed]
    [Google Scholar]
  6. Scarpellini E, Ianiro G, Attili F, Bassanelli C, De Santis A et al. The human gut microbiota and virome: potential therapeutic implications. Dig Liver Dis 2015; 47:1007–1012 [View Article] [PubMed]
    [Google Scholar]
  7. Castillo DJ, Rifkin RF, Cowan DA, Potgieter M. The healthy human blood microbiome: fact or fiction?. Front Cell Infect Microbiol 2019; 9:148 [View Article] [PubMed]
    [Google Scholar]
  8. Velmurugan G, Dinakaran V, Rajendhran J, Swaminathan K. Blood microbiota and circulating microbial metabolites in diabetes and cardiovascular disease. Trends Endocrinol Metab 2020; 31:835–847 [View Article] [PubMed]
    [Google Scholar]
  9. Whittle E, Leonard MO, Harrison R, Gant TW, Tonge DP. Multi-method characterization of the human circulating microbiome. Front Microbiol 2018; 9:3266 [View Article] [PubMed]
    [Google Scholar]
  10. Dinakaran V, Rathinavel A, Pushpanathan M, Sivakumar R, Gunasekaran P et al. Elevated levels of circulating DNA in cardiovascular disease patients: metagenomic profiling of microbiome in the circulation. PLoS One 2014; 9:e105221 [View Article] [PubMed]
    [Google Scholar]
  11. Panaiotov S, Filevski G, Equestre M, Nikolova E, Kalfin R. Cultural isolation and characteristics of the blood microbiome of healthy individuals. AiM 2018; 08:406–421 [View Article]
    [Google Scholar]
  12. Païssé S, Valle C, Servant F, Courtney M, Burcelin R et al. Comprehensive description of blood microbiome from healthy donors assessed by 16S targeted metagenomic sequencing. Transfusion 2016; 56:1138–1147 [View Article] [PubMed]
    [Google Scholar]
  13. Shah NB, Allegretti AS, Nigwekar SU, Kalim S, Zhao S et al. Blood microbiome profile in CKD: a pilot study. Clin J Am Soc Nephrol 2019; 14:692–701 [View Article] [PubMed]
    [Google Scholar]
  14. Eisenhofer R, Minich JJ, Marotz C, Cooper A, Knight R et al. Contamination in low microbial biomass microbiome studies: issues and recommendations. Trends Microbiol 2019; 27:105–117 [View Article] [PubMed]
    [Google Scholar]
  15. Salter SJ, Cox MJ, Turek EM, Calus ST, Cookson WO et al. Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol 2014; 12:87 [View Article] [PubMed]
    [Google Scholar]
  16. Hornung BVH, Zwittink RD, Kuijper EJ. Issues and current standards of controls in microbiome research. FEMS Microbiol Ecol 2019; 95:5 [View Article] [PubMed]
    [Google Scholar]
  17. Solbiati J, Frias-Lopez J. Metatranscriptome of the oral microbiome in health and disease. J Dent Res 2018; 97:492–500 [View Article] [PubMed]
    [Google Scholar]
  18. Tan CCS, Ko KKK, Chen H, Liu J, Loh M et al. No evidence for a common blood microbiome based on a population study of 9,770 healthy humans. Microbiology 2022 [View Article]
    [Google Scholar]
  19. Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome. JAMA 2015; 313:949 [View Article] [PubMed]
    [Google Scholar]
  20. Pimentel M, Lembo A. Microbiome and its role in irritable bowel syndrome. Dig Dis Sci 2020; 65:829–839 [View Article] [PubMed]
    [Google Scholar]
  21. Sperber AD, Dumitrascu D, Fukudo S, Gerson C, Ghoshal UC et al. The global prevalence of IBS in adults remains elusive due to the heterogeneity of studies: a Rome Foundation working team literature review. Gut 2017; 66:1075–1082 [View Article] [PubMed]
    [Google Scholar]
  22. Rovite V, Wolff-Sagi Y, Zaharenko L, Nikitina-Zake L, Grens E et al. Genome Database of the Latvian Population (LGDB): design, goals, and primary results. J Epidemiol 2018; 28:353–360 [View Article] [PubMed]
    [Google Scholar]
  23. Galaxy Community The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2022 update. Nucleic Acids Res 2022; 50:W345–W351 [View Article] [PubMed]
    [Google Scholar]
  24. Jahn CE, Charkowski AO, Willis DK. Evaluation of isolation methods and RNA integrity for bacterial RNA quantitation. J Microbiol Methods 2008; 75:318–324 [View Article] [PubMed]
    [Google Scholar]
  25. Veselovsky VA, Dyachkova MS, Bespiatykh DA, Yunes RA, Shitikov EA et al. The gene expression profile differs in growth phases of the Bifidobacterium longum culture. Microorganisms 2022; 10:8 [View Article] [PubMed]
    [Google Scholar]
  26. Wang Y, Lin J, Zhang T, He S, Li Y et al. Environmental contamination prevalence, antimicrobial resistance and molecular characteristics of methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis isolated from secondary schools in Guangzhou, China. Int J Environ Res Public Health 2020; 17:623 [View Article] [PubMed]
    [Google Scholar]
  27. Kell DB, Pretorius E. On the translocation of bacteria and their lipopolysaccharides between blood and peripheral locations in chronic, inflammatory diseases: the central roles of LPS and LPS-induced cell death. Integr Biol 2015; 7:1339–1377 [View Article] [PubMed]
    [Google Scholar]
  28. Camilleri M. Leaky gut: mechanisms, measurement and clinical implications in humans. Gut 2019; 68:1516–1526 [View Article] [PubMed]
    [Google Scholar]
  29. Dewhirst FE, Chen T, Izard J, Paster BJ, Tanner ACR et al. The human oral microbiome. J Bacteriol 2010; 192:5002–5017 [View Article] [PubMed]
    [Google Scholar]
  30. Lagkouvardos I, Pukall R, Abt B, Foesel BU, Meier-Kolthoff JP et al. The Mouse Intestinal Bacterial Collection (miBC) provides host-specific insight into cultured diversity and functional potential of the gut microbiota. Nat Microbiol 2016; 1:16219 [View Article] [PubMed]
    [Google Scholar]
  31. Vandamme P, Gillis M, Vancanneyt M, Hoste B, Kersters K et al. Moraxella lincolnii sp. nov., isolated from the human respiratory tract, and reevaluation of the taxonomic position of Moraxella osloensis. Int J Syst Bacteriol 1993; 43:474–481 [View Article] [PubMed]
    [Google Scholar]
  32. Ryan MP, Adley CC. Ralstonia spp.: emerging global opportunistic pathogens. Eur J Clin Microbiol Infect Dis 2014; 33:291–304 [View Article] [PubMed]
    [Google Scholar]
  33. Weyrich LS, Farrer AG, Eisenhofer R, Arriola LA, Young J et al. Laboratory contamination over time during low-biomass sample analysis. Mol Ecol Resour 2019; 19:982–996 [View Article] [PubMed]
    [Google Scholar]
  34. Karstens L, Asquith M, Davin S, Fair D, Gregory WT et al. Controlling for contaminants in low-biomass 16S rRNA gene sequencing experiments. mSystems 2019; 4:4 [View Article] [PubMed]
    [Google Scholar]
  35. Díaz S, Escobar JS, Avila FW. Identification and removal of potential contaminants in 16S rRNA gene sequence data sets from low-microbial-biomass samples: an example from mosquito tissues. mSphere 2021; 6:e0050621 [View Article] [PubMed]
    [Google Scholar]
  36. Glassing A, Dowd SE, Galandiuk S, Davis B, Chiodini RJ. Inherent bacterial DNA contamination of extraction and sequencing reagents may affect interpretation of microbiota in low bacterial biomass samples. Gut Pathog 2016; 8:24 [View Article] [PubMed]
    [Google Scholar]
  37. Fricker AM, Podlesny D, Fricke WF. What is new and relevant for sequencing-based microbiome research? A mini-review. J Adv Res 2019; 19:105–112 [View Article] [PubMed]
    [Google Scholar]
  38. Davis NM, Proctor DM, Holmes SP, Relman DA, Callahan BJ. Simple statistical identification and removal of contaminant sequences in marker-gene and metagenomics data. Microbiome 2018; 6:226 [View Article] [PubMed]
    [Google Scholar]
  39. Lusk RW. Diverse and widespread contamination evident in the unmapped depths of high throughput sequencing data. PLoS One 2014; 9:e110808 [View Article] [PubMed]
    [Google Scholar]
  40. Lazarevic V, Gaïa N, Girard M, Schrenzel J. Decontamination of 16S rRNA gene amplicon sequence datasets based on bacterial load assessment by qPCR. BMC Microbiol 2016; 16:73 [View Article] [PubMed]
    [Google Scholar]
  41. Stinson LF, Keelan JA, Payne MS. Identification and removal of contaminating microbial DNA from PCR reagents: impact on low-biomass microbiome analyses. Lett Appl Microbiol 2019; 68:2–8 [View Article] [PubMed]
    [Google Scholar]
  42. Anonymous UK Standards for Microbiology Investigations. Good Practice When Performing Molecular Amplification Assays.," Issued by the Standards Unit, National Infection Service, PHE Quality Guidance. Q 4. Issue no: 5. Issue date: 19.02.18 2018
    [Google Scholar]
  43. Reich I, Ijaz UZ, Gormally M, Smith CJ. 16S rRNA sequencing reveals likely beneficial core microbes within faecal samples of the EU protected slug Geomalacus maculosus. Sci Rep 2018; 8:10402 [View Article] [PubMed]
    [Google Scholar]
  44. Boman J, Nilson B, Sunnerhagen T, Rasmussen M. True infection or contamination in patients with positive Cutibacterium blood cultures-a retrospective cohort study. Eur J Clin Microbiol Infect Dis 2022; 41:1029–1037 [View Article] [PubMed]
    [Google Scholar]
  45. Gajdács M, Urbán E. Relevance of anaerobic bacteremia in adult patients: a never-ending story?. Eur J Microbiol Immunol 2020; 10:64–75 [View Article] [PubMed]
    [Google Scholar]
  46. Bhat SV, Maughan H, Cameron ADS, Yost CK. Phylogenomic analysis of the genus Delftia reveals distinct major lineages with ecological specializations. Microb Genom 2022; 8:mgen000864 [View Article] [PubMed]
    [Google Scholar]
  47. Panaiotov S, Hodzhev Y, Tsafarova B, Tolchkov V, Kalfin R. Culturable and non-culturable blood microbiota of healthy individuals. Microorganisms 2021; 9:1464 [View Article] [PubMed]
    [Google Scholar]
  48. Chen J, Wright K, Davis JM, Jeraldo P, Marietta EV et al. An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis. Genome Med 2016; 8:43 [View Article] [PubMed]
    [Google Scholar]
  49. Ormeño-Orrillo E, Martínez-Romero E. A genomotaxonomy view of the Bradyrhizobium genus. Front Microbiol 2019; 10: [View Article]
    [Google Scholar]
  50. Najar IN, Thakur N. A systematic review of the genera Geobacillus and Parageobacillus: their evolution, current taxonomic status and major applications. Microbiology 2020; 166:800–816 [View Article] [PubMed]
    [Google Scholar]
  51. Ryan RP, Monchy S, Cardinale M, Taghavi S, Crossman L et al. The versatility and adaptation of bacteria from the genus Stenotrophomonas. Nat Rev Microbiol 2009; 7:514–525 [View Article] [PubMed]
    [Google Scholar]
  52. Potgieter M, Bester J, Kell DB, Pretorius E. The dormant blood microbiome in chronic, inflammatory diseases. FEMS Microbiol Rev 2015; 39:567–591 [View Article] [PubMed]
    [Google Scholar]
  53. Corvec S, Dagnelie M-A, Khammari A, Dréno B. Taxonomy and phylogeny of Cutibacterium (formerly Propionibacterium) acnes in inflammatory skin diseases. Ann Dermatol Venereol 2019; 146:26–30 [View Article] [PubMed]
    [Google Scholar]
  54. Yu D, Banting G, Neumann NF. A review of the taxonomy, genetics, and biology of the genus Escherichia and the type species Escherichia coli. Can J Microbiol 2021; 67:553–571 [View Article] [PubMed]
    [Google Scholar]
  55. Jang J, Hur H-G, Sadowsky MJ, Byappanahalli MN, Yan T et al. Environmental Escherichia coli: ecology and public health implications-a review. J Appl Microbiol 2017; 123:570–581 [View Article] [PubMed]
    [Google Scholar]
  56. Jun S-R, Wassenaar TM, Nookaew I, Hauser L, Wanchai V et al. Diversity of Pseudomonas genomes, including populus-associated isolates, as revealed by comparative genome analysis. Appl Environ Microbiol 2016; 82:375–383 [View Article] [PubMed]
    [Google Scholar]
  57. Kloos WE, Tornabene TG, Schleifer KH. Isolation and characterization of micrococci from human skin, including two new species: Micrococcus lylae and Micrococcus kristinae. Int J Syst Bacteriol 1974; 24:79–101 [View Article]
    [Google Scholar]
  58. Kim J-S, Lee KC, Suh MK, Han K-I, Eom MK et al. Mediterraneibacter butyricigenes sp. nov., a butyrate-producing bacterium isolated from human faeces. J Microbiol 2019; 57:38–44 [View Article] [PubMed]
    [Google Scholar]
  59. Togo AH, Diop A, Bittar F, Maraninchi M, Valero R et al. Description of Mediterraneibacter massiliensis, gen. nov., sp. nov., a new genus isolated from the gut microbiota of an obese patient and reclassification of Ruminococcus faecis, Ruminococcus lactaris, Ruminococcus torques, Ruminococcus gnavus and Clostridium glycyrrhizinilyticum as Mediterraneibacter faecis comb. nov., Mediterraneibacter lactaris comb. nov., Mediterraneibacter torques comb. nov., Mediterraneibacter gnavus comb. nov. and Mediterraneibacter glycyrrhizinilyticus comb. nov. Antonie van Leeuwenhoek 2018; 111:2107–2128 [View Article] [PubMed]
    [Google Scholar]
  60. Lalucat J, Bennasar A, Bosch R, García-Valdés E, Palleroni NJ. Biology of Pseudomonas stutzeri. Microbiol Mol Biol Rev 2006; 70:510–547 [View Article] [PubMed]
    [Google Scholar]
  61. Bernard K. The genus corynebacterium and other medically relevant coryneform-like bacteria. J Clin Microbiol 2012; 50:3152–3158 [View Article] [PubMed]
    [Google Scholar]
  62. Liu X, Mao B, Gu J, Wu J, Cui S et al. Blautia-a new functional genus with potential probiotic properties?. Gut Microbes 2021; 13:1–21 [View Article] [PubMed]
    [Google Scholar]
  63. Qin P, Zou Y, Dai Y, Luo G, Zhang X et al. Characterization a novel butyric acid-producing bacterium Collinsella aerofaciens subsp. Shenzhenensis subsp. nov. Microorganisms 2019; 7:78 [View Article]
    [Google Scholar]
  64. Touchon M, Cury J, Yoon E-J, Krizova L, Cerqueira GC et al. The genomic diversification of the whole Acinetobacter genus: origins, mechanisms, and consequences. Genome Biol Evol 2014; 6:2866–2882 [View Article] [PubMed]
    [Google Scholar]
  65. Gupta AK, Batra R, Bluhm R, Boekhout T, Dawson TL. Skin diseases associated with Malassezia species. J Am Acad Dermatol 2004; 51:785–798 [View Article] [PubMed]
    [Google Scholar]
  66. Bagley ST. Habitat association of Klebsiella species. Infect Control 1985; 6:52–58 [View Article] [PubMed]
    [Google Scholar]
  67. Holdeman LV, Moore WEC. New genus, Coprococcus, twelve new species, and emended descriptions of four previously described species of bacteria from human feces. Int J Syst Bacteriol 1974; 24:260–277 [View Article]
    [Google Scholar]
  68. Le Roy T, Moens de Hase E, Van Hul M, Paquot A, Pelicaen R et al. Dysosmobacter welbionis is a newly isolated human commensal bacterium preventing diet-induced obesity and metabolic disorders in mice. Gut 2022; 71:534–543 [View Article] [PubMed]
    [Google Scholar]
  69. Schwiertz A, Hold GL, Duncan SH, Gruhl B, Collins MD et al. Anaerostipes caccae gen. nov., sp. nov., a new saccharolytic, acetate-utilising, butyrate-producing bacterium from human faeces. Syst Appl Microbiol 2002; 25:46–51 [View Article] [PubMed]
    [Google Scholar]
  70. Benevides L, Burman S, Martin R, Robert V, Thomas M et al. New insights into the diversity of the genus Faecalibacterium. Front Microbiol 2017; 8:1790 [View Article] [PubMed]
    [Google Scholar]
  71. Ross AA, Müller KM, Weese JS, Neufeld JD. Comprehensive skin microbiome analysis reveals the uniqueness of human skin and evidence for phylosymbiosis within the class Mammalia. Proc Natl Acad Sci 2018; 115:E5786–E5795 [View Article] [PubMed]
    [Google Scholar]
  72. Rodríguez JM, Murphy K, Stanton C, Ross RP, Kober OI et al. The composition of the gut microbiota throughout life, with an emphasis on early life. Microb Ecol Health Dis 2015; 26:26050 [View Article] [PubMed]
    [Google Scholar]
  73. Chattopadhyay I, Verma M, Panda M. Role of oral microbiome signatures in diagnosis and prognosis of oral cancer. Technol Cancer Res Treat 2019; 18:1533033819867354 [View Article] [PubMed]
    [Google Scholar]
  74. Companys J, Gosalbes MJ, Pla-Pagà L, Calderón-Pérez L, Llauradó E et al. Gut microbiota profile and its association with clinical variables and dietary intake in overweight/obese and lean subjects: a cross-sectional study. Nutrients 2021; 13:2032 [View Article] [PubMed]
    [Google Scholar]
  75. Liu C, Du M-X, Abuduaini R, Yu H-Y, Li D-H et al. Enlightening the taxonomy darkness of human gut microbiomes with a cultured biobank. Microbiome 2021; 9:119 [View Article] [PubMed]
    [Google Scholar]
  76. Turroni F, van Sinderen D, Ventura M. Genomics and ecological overview of the genus Bifidobacterium. Int J Food Microbiol 2011; 149:37–44 [View Article] [PubMed]
    [Google Scholar]
  77. Parker BJ, Wearsch PA, Veloo ACM, Rodriguez-Palacios A. The genus Alistipes: gut bacteria with emerging implications to inflammation, cancer, and mental health. Front Immunol 2020; 11:906 [View Article] [PubMed]
    [Google Scholar]
  78. Könönen E, Gursoy UK. Oral Prevotella species and their connection to events of clinical relevance in gastrointestinal and respiratory tracts. Front Microbiol 2021; 12:798763 [View Article] [PubMed]
    [Google Scholar]
  79. Accetto T, Avguštin G. Non-oral Prevotella stepping into the spotlight. Anaerobe 2021; 68:102321 [View Article] [PubMed]
    [Google Scholar]
  80. La Reau AJ, Suen G. The Ruminococci: key symbionts of the gut ecosystem. J Microbiol 2018; 56:199–208 [View Article] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.001719
Loading
/content/journal/jmm/10.1099/jmm.0.001719
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error